CongenitalPaediatricICD-10 Q84.8

Aplasia cutis congenita

ACC ยท congenital absence of skin ยท congenital scar

Aplasia cutis congenita is a heterogeneous group of congenital disorders characterised by localised or extensive absence of skin at birth. The commonest form is solitary scalp ACC (Type 1; Frieden classification). Lesions may be simple skin defects, deeper defects involving bone or dura, or part of complex syndromes (Adams-Oliver, trisomy 13, Bart syndrome). Skin-oncology relevance is principally as a clinical sign within Schimmelpenning / naevus sebaceus / Bart syndrome and as a wound-healing / reconstruction challenge.

CurrentLast reviewed 16 May 2026
Clinical image of Aplasia cutis congenita
Aplasia cutis congenita. Image sourced from DermNet New Zealand. Used under CC BY-NC-ND 4.0. No endorsement implied.

Frieden 1986 classification

  • Type 1: scalp ACC without other anomalies (commonest).
  • Type 2: scalp ACC with limb anomalies (Adams-Oliver syndrome).
  • Type 3: ACC with epidermal naevi (Schimmelpenning, naevus sebaceus).
  • Type 4: ACC overlying embryological malformations (myelomeningocele, omphalocele).
  • Type 5: ACC with foetus papyraceus (placental infarction).
  • Type 6: ACC with epidermolysis bullosa (Bart syndrome).
  • Type 7: ACC limited to limbs (without EB).
  • Type 8: ACC caused by teratogens (methimazole, misoprostol, valproate, intrauterine infection โ€” varicella, HSV).
  • Type 9: ACC as part of chromosomal / malformation syndromes (trisomy 13, 4p- syndrome).

Clinical features

  • Single or multiple well-demarcated areas of absent skin at birth.
  • Size: few mm to several cm; may involve bone / dura in deeper lesions.
  • Sites:
    • Vertex of scalp (commonest โ€” ~70%).
    • Trunk, limbs.
  • Appearance:
    • Glistening atrophic membrane (membranous ACC) โ€” better prognosis.
    • Ulcer with granulation tissue.
    • Stellate / linear scar at birth.
  • Hair collar sign: dense ring of long dark hair around ACC; marker of underlying neural-tube anomaly (cephalocele) โ†’ imaging mandatory.
  • Frieden Type 2 (Adams-Oliver): limb deficiency (transverse digital anomaly), cutis marmorata telangiectatica congenita (CMTC), congenital heart disease.
  • Frieden Type 3: associated epidermal naevus / naevus sebaceus.

Workup

  • Imaging:
    • Cranial USS or MRI for any scalp ACC with hair-collar sign, bony defect or midline location.
    • Spinal MRI if lumbosacral ACC (dysraphism).
    • Cardiac echo if Adams-Oliver suspected.
  • Examination for limb anomalies (Adams-Oliver), epidermal naevi (Schimmelpenning Type 3), EB phenotype (Bart Type 6).
  • Maternal drug / infection history (Type 8).
  • Karyotype / microarray if dysmorphic / multi-system.
  • Photography for follow-up.

Management

  • Small / membranous ACC:
    • Conservative โ€” bland emollient, non-adherent dressing.
    • Heal by secondary intention over weeks.
    • Residual atrophic scar; cosmetic refinement later.
  • Large or deep ACC:
    • Multidisciplinary plastic / paediatric / neurosurgical input.
    • Risk of haemorrhage (especially scalp involving dura / sagittal sinus).
    • Risk of meningitis / infection โ€” sterile dressings, prophylactic antibiotics if indicated.
    • Surgical: split-thickness skin graft, dermal substitute (Integra), tissue expansion, free flap.
  • Syndromic forms:
    • Clinical genetics referral.
    • Cardiology if Adams-Oliver.
    • Surveillance per associated syndrome.
  • Long-term cosmetic / reconstructive follow-up; psychological support for family.

References

  1. Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986;14:646-660.
  2. Drolet BA, Esterly NB. The hair collar sign: marker for cranial dysraphism. Pediatrics. 1995;96:309-313.
  3. Bharti G et al. Aplasia cutis congenita: clinical management of a rare congenital anomaly. J Craniofac Surg. 2011;22:159-165.
  4. Adams FH, Oliver CP. Hereditary deformities in man due to arrested development. J Hered. 1945;36:3-7.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.